NO20004881L - Pyrrolo[1,2-a]pyrazin sPLA2 inhibitor - Google Patents
Pyrrolo[1,2-a]pyrazin sPLA2 inhibitorInfo
- Publication number
- NO20004881L NO20004881L NO20004881A NO20004881A NO20004881L NO 20004881 L NO20004881 L NO 20004881L NO 20004881 A NO20004881 A NO 20004881A NO 20004881 A NO20004881 A NO 20004881A NO 20004881 L NO20004881 L NO 20004881L
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolo
- pyrazine
- atoms
- similar
- group
- Prior art date
Links
- QSLLFYVBWXWUQT-UHFFFAOYSA-N 7-Azaindolizine Chemical compound C1=NC=CN2C=CC=C21 QSLLFYVBWXWUQT-UHFFFAOYSA-N 0.000 title 2
- 102000005473 Secretory Phospholipases A2 Human genes 0.000 title 1
- 108010031873 Secretory Phospholipases A2 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000004429 atom Chemical group 0.000 abstract 2
- 125000002837 carbocyclic group Chemical group 0.000 abstract 2
- 230000002452 interceptive effect Effects 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000000651 prodrug Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8599798 | 1998-03-31 | ||
| JP24473598 | 1998-08-31 | ||
| PCT/JP1999/001670 WO1999051605A1 (en) | 1998-03-31 | 1999-03-31 | PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004881D0 NO20004881D0 (no) | 2000-09-28 |
| NO20004881L true NO20004881L (no) | 2000-11-28 |
Family
ID=26427020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004881A NO20004881L (no) | 1998-03-31 | 2000-09-28 | Pyrrolo[1,2-a]pyrazin sPLA2 inhibitor |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6407104B1 (https=) |
| EP (1) | EP1066290A1 (https=) |
| JP (1) | JP4412521B2 (https=) |
| KR (1) | KR20010042307A (https=) |
| CN (1) | CN1303384A (https=) |
| AU (1) | AU3054399A (https=) |
| BR (1) | BR9909345A (https=) |
| CA (1) | CA2326522A1 (https=) |
| HU (1) | HUP0102981A3 (https=) |
| NO (1) | NO20004881L (https=) |
| WO (1) | WO1999051605A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2346334A1 (en) | 1998-10-14 | 2000-04-20 | Shionogi & Co., Ltd. | Composition for treating or preventing ischemia reperfusion injury |
| JP4636521B2 (ja) | 1999-07-19 | 2011-02-23 | 塩野義製薬株式会社 | ｓＰＬＡ２阻害作用を有する三環系化合物 |
| US6787545B1 (en) | 1999-08-23 | 2004-09-07 | Shiongi & Co., Ltd. | Pyrrolotriazine derivatives having spla2-inhibitory activities |
| AU7559600A (en) * | 1999-10-15 | 2001-04-23 | Shionogi & Co., Ltd. | V type and/or x type spla2 inhibitors |
| US6756376B1 (en) | 1999-11-15 | 2004-06-29 | Shionogi & Co., Ltd. | Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities |
| AU2001267825A1 (en) | 2000-06-29 | 2002-01-08 | Shionogi And Co., Ltd. | Remedies for cirrhosis |
| AU2001267823A1 (en) * | 2000-06-29 | 2002-01-08 | Shionogi And Co., Ltd. | Compounds exhibiting x-type spla2 inhibiting effect |
| AUPQ876400A0 (en) * | 2000-07-14 | 2000-08-03 | University Of Queensland, The | Compositions and method of using them |
| WO2002012249A2 (en) * | 2000-08-04 | 2002-02-14 | Eli Lilly And Company | Substituted pyrrole compounds and their use as spla2 inhibitors |
| TWI314457B (https=) * | 2001-03-19 | 2009-09-11 | Shionogi & Co | |
| US6730694B1 (en) | 2001-07-20 | 2004-05-04 | Eli Lilly And Company | sPLA2 inhibitors |
| DE10155727A1 (de) * | 2001-11-13 | 2003-05-28 | Morphochem Ag | Serin Protease Inhibitoren |
| AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
| DK1910384T3 (da) * | 2005-08-04 | 2012-12-17 | Sirtris Pharmaceuticals Inc | Imidazo [2,1-b] thiazol-derivater som sirtuinmodulerende forbindelser |
| CL2008001822A1 (es) * | 2007-06-20 | 2009-03-13 | Sirtris Pharmaceuticals Inc | Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras. |
| SG175390A1 (en) | 2009-04-29 | 2011-12-29 | Amarin Corp Plc | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| CN105622616A (zh) * | 2016-02-25 | 2016-06-01 | 上海雅本化学有限公司 | 一种4-氯吡咯并嘧啶的制备方法 |
| EP4378924A4 (en) * | 2021-09-17 | 2025-09-03 | Mitsui Chemicals Inc | PROCESS FOR PRODUCING A (METH)ACRYLAMIDE COMPOUND |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109309A (en) * | 1993-04-16 | 2000-06-29 | Lilly Co Eli | 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them |
| IL109311A0 (en) | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
| PL180523B1 (pl) | 1994-04-01 | 2001-02-28 | Eli Lilly & Co | Nowy zwiazek, pochodna 1H-indolo-3-glioksylamidu i srodek farmaceutyczny PL PL PL PL PL PL PL PL PL PL |
| JPH10505584A (ja) | 1994-07-21 | 1998-06-02 | イーライ・リリー・アンド・カンパニー | インドリジンｓＰＬＡ▲下２▼インヒビター |
| US5641800A (en) | 1994-07-21 | 1997-06-24 | Eli Lilly And Company | 1H-indole-1-functional sPLA2 inhibitors |
| US6214876B1 (en) * | 1994-07-21 | 2001-04-10 | Eli Lilly And Company | Indene-1-acetamide sPLA2 inhibitors |
| AU1289797A (en) | 1995-12-13 | 1997-07-03 | Eli Lilly And Company | Naphthyl acetamides as spla2 inhibitors |
| KR19990072111A (ko) | 1995-12-13 | 1999-09-27 | 피터 지. 스트링거 | Spla2 억제제인 나프틸 글리옥스아미드 |
| JP2001503055A (ja) | 1996-10-30 | 2001-03-06 | イーライ・リリー・アンド・カンパニー | 置換三環化合物群 |
| US6353128B1 (en) | 1996-12-03 | 2002-03-05 | Eli Lilly And Company | Phenyl acetamides as sPLA2 inhibitors |
| US5916922A (en) | 1996-12-03 | 1999-06-29 | Eli Lilly And Company | Phenyl glyoxamides as SPLA2 inhibitors |
| ID18983A (id) | 1996-12-04 | 1998-05-28 | Lilly Co Eli | Pirazola sebagai inhibitor sekresi fosfolipase a2 non-pankreas pada manusia |
| US5919774A (en) | 1996-12-10 | 1999-07-06 | Eli Lilly And Company | Pyrroles as sPLA2 inhibitors |
| TW455581B (en) | 1997-06-26 | 2001-09-21 | Lilly Co Eli | Process for preparing 4-substituted-1H-indole-3-glyoxamides |
-
1999
- 1999-03-31 AU AU30543/99A patent/AU3054399A/en not_active Abandoned
- 1999-03-31 CA CA002326522A patent/CA2326522A1/en not_active Abandoned
- 1999-03-31 JP JP2000542326A patent/JP4412521B2/ja not_active Expired - Fee Related
- 1999-03-31 KR KR1020007010855A patent/KR20010042307A/ko not_active Ceased
- 1999-03-31 BR BR9909345-6A patent/BR9909345A/pt not_active IP Right Cessation
- 1999-03-31 US US09/623,591 patent/US6407104B1/en not_active Expired - Fee Related
- 1999-03-31 CN CN99806627A patent/CN1303384A/zh active Pending
- 1999-03-31 HU HU0102981A patent/HUP0102981A3/hu unknown
- 1999-03-31 WO PCT/JP1999/001670 patent/WO1999051605A1/en not_active Ceased
- 1999-03-31 EP EP99912066A patent/EP1066290A1/en not_active Ceased
-
2000
- 2000-09-28 NO NO20004881A patent/NO20004881L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010042307A (ko) | 2001-05-25 |
| HUP0102981A3 (en) | 2002-10-28 |
| HUP0102981A2 (hu) | 2002-01-28 |
| US6407104B1 (en) | 2002-06-18 |
| CN1303384A (zh) | 2001-07-11 |
| WO1999051605A1 (en) | 1999-10-14 |
| AU3054399A (en) | 1999-10-25 |
| JP2002530268A (ja) | 2002-09-17 |
| JP4412521B2 (ja) | 2010-02-10 |
| CA2326522A1 (en) | 1999-10-14 |
| NO20004881D0 (no) | 2000-09-28 |
| EP1066290A1 (en) | 2001-01-10 |
| BR9909345A (pt) | 2000-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004881L (no) | Pyrrolo[1,2-a]pyrazin sPLA2 inhibitor | |
| BR9911048A (pt) | Inibidor de spla2 de pirrolo[1,2-b]piridazina | |
| EP0989129A4 (en) | PYRAZOLOPYRIDYLPYRAZINONE DERIVATIVES AND A METHOD FOR THE PRODUCTION THEREOF | |
| NO20012570L (no) | Substituerte benzimidazoler og deres anvendelse som PARP- inhibitorer | |
| NZ507564A (en) | 4-substituted carbazole or tetrahydrocarbazole derivatives | |
| DK1106612T3 (da) | Quinolinderivater, der er nyttige til inhibering af farnesylproteintransferase | |
| CA2205757A1 (en) | Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii) | |
| IL156873A0 (en) | Pharmaceutically active piperidine derivatives | |
| DK0628550T3 (da) | Pyridazin som interleukin-1 beta-omdannede enzyminhibitorer | |
| ATE202567T1 (de) | Phosphorsäurediester-derivate | |
| DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
| HRP20000585B1 (en) | Substituted bisindolymaleimides for the inhibition of cell proliferation | |
| TW200624541A (en) | Flameproof rubber-reinforced styrenic resin composition | |
| NO304885B1 (no) | Nipectoin syrederivater som antitrombe forbindelser | |
| YU19099A (sh) | Supstituisani tricikli | |
| CA2209422A1 (en) | 4-amino-3-acylnaphthyridine derivatives | |
| NO983444L (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer | |
| EP0995744A4 (en) | CIS-SUBSTITUTED DERIVATIVES OF FLUOROMETHYLPYRROLIDINE | |
| NO934227L (no) | Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse | |
| TW262467B (https=) | ||
| EP0133038A3 (en) | Octahydroindolizinepropanoic acid derivatives as enzyme inhibitors | |
| AP2001002314A0 (en) | Substituted benzolactam compounds. | |
| ES8704881A1 (es) | Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos. | |
| ATE223907T1 (de) | Arginnin analoge mit no- syntax inhibierenderwirkung | |
| BG102429A (en) | Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means |